机构：[1]Department of Radiology, West China Hospital, Sichuan University, No 37, Guoxue Alley, Chengdu 610041, Sichuan, China四川大学华西医院[2]Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[3]Department of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China[4]Department of Radiology, Sanya People’s Hospital, Sanya, Hainan, China
This work was supported by the Science and Technology
Support Program of Sichuan Province (Grant No. 2021YFS0021);
China Postdoctoral Science Foundation (Grant No. 2021M692289);
Post-Doctor Research Project, West China Hospital, Sichuan University
(Grant No. 2020HXBH130); and National Natural Science Foundation
of China (Grant No. 81971571).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|3 区医学
小类|3 区核医学
第一作者：
第一作者机构：[1]Department of Radiology, West China Hospital, Sichuan University, No 37, Guoxue Alley, Chengdu 610041, Sichuan, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Radiology, West China Hospital, Sichuan University, No 37, Guoxue Alley, Chengdu 610041, Sichuan, China[4]Department of Radiology, Sanya People’s Hospital, Sanya, Hainan, China
推荐引用方式(GB/T 7714)：
Feng Che,Yi Wei,Qing Xu,et al.Noninvasive identification of SOX9 status using radiomics signatures may help construct personalized treatment strategy in hepatocellular carcinoma[J].Abdominal Radiology (New York).2024,doi:10.1007/s00261-024-04190-2.
APA：
Feng Che,Yi Wei,Qing Xu,Qian Li,Tong Zhang...&Bin Song.(2024).Noninvasive identification of SOX9 status using radiomics signatures may help construct personalized treatment strategy in hepatocellular carcinoma.Abdominal Radiology (New York),,
MLA：
Feng Che,et al."Noninvasive identification of SOX9 status using radiomics signatures may help construct personalized treatment strategy in hepatocellular carcinoma".Abdominal Radiology (New York) .(2024)
